Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Echosens a annoncé aujourd'hui la nomination de Victor de Lédinghen, docteur en médecine et docteur ès sciences, au poste de directeur médical de...
Echosens ha annunciato oggi la nomina di Victor de Lédinghen, MD PhD, a nuovo Chief Medical Officer dell'azienda. Con oltre due decenni di esperienza ...
Echosens gab heute die Ernennung von Victor de Lédinghen, MD PhD, zum neuen Medizinischen Leiter des Unternehmens bekannt. Mit mehr als zwei...
Echosens anunció hoy el nombramiento de Victor de Lédinghen, MD PhD, como nuevo director médico de la empresa. Con más de dos décadas de experiencia...
Echosens announced today the appointment of Victor de Lédinghen, MD PhD, as the company's new Chief Medical Officer. With over two decades of...
More than 100 million people in the U.S. are affected by some form of liver disease, but only 4.5 million adults have been diagnosed with the...
La Asociación Estadounidense para el Estudio de la Enfermedad Hepática (AASLD) ha publicado una nueva guía que recomienda pruebas no invasivas como...
L'American Association for the Study of Liver Disease (AASLD) a publié de nouvelles lignes directrices préconisant des tests non invasifs comme...
Die American Association for the Study of Liver Disease (AASLD) hat neue Leitlinien veröffentlicht, in denen nichtinvasive Tests wie der FibroScan®...
The American Association for the Study of Liver Disease (AASLD) has released new guidance advocating noninvasive tests like FibroScan® for the...
As we approach October's National Liver Health Awareness Month, Echosens, a manufacturer of non-invasive diagnostic technology, FibroScan®, is...
Most people don't show symptoms of liver disease until it has progressed to an advanced stage, at which point no treatments are available. To help...
The U.S. Food and Drug Administration (FDA) has cleared expanded Indications for Use for screening with FibroScan®, the non-invasive liver management ...
The growing prevalence of fatty liver disease in the U.S. has led the American Association for the Study of Liver Diseases (AASLD) to call for...
A Echosens anunciou hoje que a empresa recebeu um parecer favorável do internacionalmente bastante estimado Tribunal Federal de Justiça alemão...
Echosens ha anunciado hoy que la sentencia recibida por parte del internacionalmente apreciado Tribunal Federal Alemán de Justicia...
Echosens hat heute bekannt gegeben, dass der international hoch angesehene Bundesgerichtshof in Karlsruhe in der von Echosens gegen das chinesische...
La société Echosens a annoncé aujourd'hui avoir reçu une décision favorable de la Cour fédérale de justice allemande (Bundesgerichtshof), réputée...
Echosens announced today that the company has received a favorable ruling from the internationally highly esteemed German Federal Court of Justice...
Echosens, empresa francesa de alta tecnología que desarrolla, fabrica y comercializa la gama de dispositivos médicos FibroScan®, destinados a la...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.